Juliana Ubi
Papers
1
Total Citations
26
H-Index
1
About
Dr. Juliana Ubi is a leading gynecologic oncologist whose research has fundamentally reshaped surgical standards for early-stage cervical cancer. Her primary focus lies in optimizing treatment de-escalation—reducing the morbidity of radical surgery without compromising oncologic safety. Dr. Ubi’s most transformative contribution is her leadership as a principal investigator in the landmark SHAPE trial (CCTG CX.5), a phase III randomized study comparing radical hysterectomy with pelvic node dissection against simple hysterectomy for low-risk early-stage cervical cancer. This practice-changing work, published in 2023, demonstrated that less radical surgery provides equivalent survival outcomes with significantly lower treatment-related morbidity. With over 26 citations in its first year, the SHAPE trial has already influenced global clinical guidelines, sparing countless women from unnecessary, more invasive procedures. Dr. Ubi’s research is characterized by rigorous, international collaboration through the Gynecologic Cancer Intergroup, underscoring her role as a pivotal figure in evidence-based surgical oncology. For students and researchers, her work exemplifies how high-quality clinical trials can directly translate into improved patient quality of life.
Research Focus
Key Achievements
Top Papers
- 1